Applied DNA Announces Pricing of $12 Million Public Offering

STONY BROOK, NY – Applied DNA Sciences, Inc. (NASDAQ:APDN) has announced the pricing of a public offering. The company expects gross proceeds of approximately $12 million before fees and other expenses. The offering consists of 9,230,769 Units, each including options for common stock or pre-funded warrants, Series A Warrants, and Series B Warrants.

Each Unit is priced at $1.30 with a common share. The Series A Warrants and Series B Warrants are priced at $1.99 per share. The proceeds will fund Applied DNA's Therapeutic DNA Production Services and MDx Testing Services, as well as general corporate purposes. The offering is expected to close around May 29, 2024, pending customary conditions.

Craig-Hallum and Laidlaw & Company (UK) Ltd. are acting as placement agents. The offer is registered under the SEC, and a final prospectus will be available on the SEC's website.